Health

Compared to Yervoy, Merck’s Keytruda improved cancer survival

Compared to Yervoy, Merck’s Keytruda improved cancer survival

Compared to Yervoy, Merck’s  Keytruda improved cancer survival 

Merck drug Keytruda is hogging the limelight right now across the world. In medical fraternity, especially among the cancer specialists, this drug is the most talked about at the moment.

The drug, Keytruda, that has been developed by none other than Merck & Co. is useful in not one cancer conditions, but against three different types of cancer.

Latest reports suggest that Merck drug Keytruda is actually affective against three cancer conditions including melanoma, lung cancer and mesothelioma. The findings of three different studies in this regard were presented earlier today at the American Association for Cancer Research conference in Philadelphia.

lung cancerIn case of Melanoma, the study suggests that Merck came out with first head-to-head comparison of two approved “immune checkpoint inhibitors,” its Keytruda and Yervoy, as initial therapy for patients with advanced melanoma. Study suggests that compared to Yervoy, Keytruda improved survival without cancer worsening by 42 percent after 6 months and boosted overall survival more than 30 percent after a year. it is needless to say that this is a worthwhile improvement in the condition of cancer patients. The study further suggests that about 33 percent of patients on Keytruda responded, meaning their tumors shrank or disappeared, versus 12 percent getting Yervoy. Serious side effects occurred a bit sooner and more commonly in the Yervoy group.

When it comes to the lung cancer, Merck actually tested Keytruda in patients with advanced non-small cell lung cancer. The study claims that on average, patients survived for 12 months, including nearly 4 months without the cancer worsening, and 20 percent responded, meaning their tumors shrank or disappeared.

More in Health

  • Measures Taken by the Government to mainstream AYUSH System of medicine

    Measures Taken by the Government to mainstream AYUSH System of medicine NVONews Desk, New Delhi: The National Policy on Indian Systems of Medicine & Homoeopathy – 2002, envisages integration of AYUSH with the Health Care Delivery System. Mainstreaming of AYUSH is one of the strategies in National Health Mission (NHM) as well...

  • CSIR conducts research on benefits of medicines made from cow urine in chronic diseases

    CSIR conducts research on benefits of medicines made from cow urine in chronic diseases New Delhi: Council...

  • Prime Minister Modi lays foundation stone of newest AIIMS in Bathinda

    NVONews Desk, Bathinda: The Prime Minister, Shri Narendra Modi, today laid the Foundation Stone of the All India Institute of Medical Sciences (AIIMS) at Bathinda in Punjab. Speaking on the occasion, the Prime Minister said that social infrastructure is essential for the development of every nation, and therefore, we need top quality...

  • Vice President Ansari says neglect of healthcare will have negative impact on India’s economy

    Vice President Ansari says neglect of healthcare will have a negative impact on India’s economy New Delhi: The Vice President of India, M. Hamid Ansari has said that neglect of healthcare will have a negative impact on India’s economy combined with rising population. He was addressing on the occasion of 20th Anniversary...

  • Mass mobilization programmes for sanitation awareness taken up across the country

    Mass mobilization programmes for sanitation awareness taken up across the country New Delhi: Rallies, shramadan, village and ward level meetings were organized today in rural and urban areas across the county for further sensitizing the people about cleanliness on the first day of Swachh Bharat Week. Minister of Urban Development Shri M.Venkaiah...

  • MoU signed between CCRAS and University of Latvia

    MoU signed between Central Council for Research in Ayurvedic Sciences (CCRAS) and University of Latvia New Delhi: A Memorandum of Understanding (MOU) between the Central Council for Research in Ayurvedic Sciences (CCRAS) and University of Latvia on establishment of an academic chair in Ayurveda was signed today at AYUSH Bhawan, New Delhi....

  • JNMC organizes workshop on ‘Role of Ultrasonography in Regional Anaesthesia and Pain Management’

    JNMC organizes workshop on ‘Role of Ultrasonography in Regional Anaesthesia and Pain Management’ Aligarh: The Department of Anaesthesiology, Jawaharlal Nehru Medical College (JNMC) and ‘Critical Care’ today organised a day-long Symposium-cum-Workshop on the role of ‘Ultrasonography in Regional Anaesthesia and Pain Management’. Aligarh Muslim University Vice Chancellor, Lt General Zameer Uddin Shah...

  • Prof Anees carries out successful Whipple’s Procedure on four patients

    Prof Anees carries out successful Whipple’s Procedure on four patients Aligarh: The Department of Surgery, J N Medical College (JNMC), Aligarh Muslim University reached another milestone after four patients were treated with a successful Whipple’s Procedure done by Professor Afzal Anees and his team. The patients, who have recovered will soon be...